Compare DG & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DG | DXCM |
|---|---|---|
| Founded | 1939 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 25.9B |
| IPO Year | N/A | 2005 |
| Metric | DG | DXCM |
|---|---|---|
| Price | $143.04 | $70.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 21 |
| Target Price | ★ $130.90 | $86.86 |
| AVG Volume (30 Days) | 3.8M | ★ 4.5M |
| Earning Date | 12-04-2025 | 02-12-2026 |
| Dividend Yield | ★ 1.63% | N/A |
| EPS Growth | N/A | ★ 7.75 |
| EPS | ★ 5.79 | 1.80 |
| Revenue | ★ $42,117,664,000.00 | $4,515,900,000.00 |
| Revenue This Year | $7.95 | $17.38 |
| Revenue Next Year | $4.18 | $12.76 |
| P/E Ratio | ★ $24.98 | $38.90 |
| Revenue Growth | 4.86 | ★ 14.21 |
| 52 Week Low | $66.43 | $54.11 |
| 52 Week High | $146.19 | $93.25 |
| Indicator | DG | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 68.09 |
| Support Level | $132.57 | $65.19 |
| Resistance Level | $146.19 | $68.18 |
| Average True Range (ATR) | 3.49 | 1.51 |
| MACD | -0.26 | 0.20 |
| Stochastic Oscillator | 77.06 | 87.78 |
Since its beginning in 1939, Dollar General has grown to become the largest dollar store operator in the United States, with more than 20,000 small-box discount stores across 48 states. The firm generated $40 billion in fiscal 2024 sales. The retailer maintains a heavy concentration of stores in rural and low-income markets underserved by big-box retailers. It's 11,000 stock-keeping units, including 2,000 priced at $1 or less, span consumables (82% of sales), seasonal items (10%), home products (5%), and apparel (3%). More than 20% of sales are derived from private label.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.